Stock info Bristol-Myers Squibb | Filter  Basic-Info

Bristol-Myers Squibb

The past year was a good year for Bristol-Myers Squibb investors

Over the last 12 months, that were loss-making period for the investors in Bristol-Myers Squibb, the stock lost around 12 percent. Over the past 5 years the stock rose a massive 68,35 percent. Bristol-Myers Squibb's revenues between 2011 and 2015 were very constant and moved between 17,62 billion dollars and 16,56 billion dollars. During 2011 and 2015 Bristol-Myers Squibb's net results were very volatile and fluctuated between 5,26 billion dollars and 1,63 billion dollars.

The headquarter of Bristol-Myers Squibb is based in New York. The company mostly operates in the pharmaceutical sector. Lamberto Andreotti is the company' CEO. Bristol-Myers Squibb has Charles Bancroft as CFO financial responsible for the company. The past 10 years the (international) industry gained at around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

The American company paid out dividends in the past 5 years. On average the Bristol-Myers Squibb stock yielded a delivered a dividend yield of around 7,05 percent over the past 5 years.

Healthy financed: not so much debt Bristol-Myers Squibb

At the end of 2015 the American company's balance sheet was worth 31,75 billion dollars. The total debt was around 17,48 billion dollars. This is 55,06 percent of the total balance sheet. As per the end of 2015 Bristol-Myers Squibb's price/earnings-ratio equaled 51. So investors paid for 1 stock 51 times the earnings per share of 2015. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the pharmaceutical company's market capitalization (the number of shares times the market price) equaled around 111,74 billion dollars. At the end of 2015 the American company had around 1,66 billion stocks listed on the exchanges.

All Bristol-Myers Squibb's financial reports are available here. More information about Bristol-Myers Squibb can be found it's website. .